Capital Impact Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$1.06 - $1.67 $199,048 - $313,595
-187,782 Reduced 36.36%
328,667 $381,000
Q4 2023

Feb 14, 2024
BUY
$1.26 - $1.79 $421,294 - $598,506
334,361 Added 183.63%
516,449 $872,000
Q1 2023

May 23, 2023
BUY
$1.2 - $2.19 $161,457 - $294,660
134,548 Added 283.02%
182,088 $242,000
Q4 2022

Feb 14, 2023
SELL
$1.63 - $3.52 $12,094 - $26,118
-7,420 Reduced 13.5%
47,540 $80,000
Q3 2022

Nov 21, 2022
BUY
$0.73 - $3.74 $40,120 - $205,550
54,960 New
54,960 $118,000

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email